Brii Biosciences and Qpex Biopharma Enter into Agreement to Acquire Global Rights for BRII-693

Brii Biosciences and Qpex Biopharma Enter into Agreement to Acquire Global Rights for BRII-693

By, Admin 27 June 2023

Brii Biosciences has recently made an announcement regarding its strategic agreements with Qpex Biopharma and other third parties. Under the terms of the agreement, Brii Bio has reached an agreement to acquire exclusive global rights for the development and commercialisation of BRII-693 (also known as QPX9003). Previously, Brii Bio held exclusive rights to this product in Greater China, but with this agreement, it will expand its rights globally. As part of the agreement, Brii Bio will return its exclusive rights to QPX7728-based products, namely BRII-636 and BRII-672, in Greater China to Qpex. This means that Brii Bio will no longer have exclusive rights to develop and commercialise these products in Greater China. BRII-693 is a novel synthetic lipopeptide being developed specifically for the treatment of critically ill patients who are suffering from multidrug-resistant (MDR) or extensively drug-resistant (XDR) gram-negative bacterial infections. These infections, particularly caused by carbapenem-resistant strains of Acinetobacter baumannii and Pseudomonas aeruginosa, pose a significant challenge in healthcare settings due to their resistance to commonly used antibiotics.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!